跳至主要内容
临床试验/ITMCTR2000003487
ITMCTR2000003487招募中1 期

The clinical efficacy of external application of mirabilite and rhubarb combined with intrathoracic chemotherapy in treating malignant pleural effusion: a prospective, randomized, controlled clinical trial

onghua Hospital affiliated to Shanghai University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • (1) At least 1 imaging examination (X-ray, B-ultrasound) showed moderate or above malignant pleural effusion, and the time between imaging examination and inclusion was <= 2 weeks.
  • (2) Advanced malignant tumor with malignant pleural effusion confirmed by histopathology or cytology.
  • (3) The expected survival time is more than 3 months, and the age of 18 <= 80 years.
  • (4) Karnofsky score >= 60, ECOG PS score <= 2.
  • (5) No serious heart, kidney, liver diseases or other therapeutic contraindications.
  • (6) No chemotherapy or intrathoracic drug injection was performed within 1 month before the inclusion of treatment, except for diagnostic puncture.
  • (7) Sign informed consent and receive medical treatment.

排除标准

  • (1) End-stage patients with cachexia and severe hypoproteinemia, unable to complete one course of treatment.
  • (2) Pregnant women, patients with mental disorders and those who do not cooperate with treatment.

研究者

发起方
onghua Hospital affiliated to Shanghai University of Chinese Medicine

相似试验